At 6 months, there was an

increase of 4.3% in the FEV1 in the EBV group (an increase of 1.0 percentage point in the percent of the predicted value), as compared with a decrease of 2.5% in the control group (a decrease of 0.9 percentage point in the percent of the predicted value). Thus, there was a mean between-group difference of 6.8% in the FEV1 (P = 0.005). Roughly similar between-group differences were observed for the 6-minute walk test. At 12 months, the rate of the complications composite was 10.3% in the EBV group versus 4.6% in the control group (P = 0.17). At 90 days, in the EBV group, as compared with the control group, there were increased rates of exacerbation Y-27632 in vitro NCT-501 clinical trial of chronic obstructive pulmonary disease (COPD) requiring hospitalization (7.9% vs. 1.1%, P = 0.03) and hemoptysis (6.1% vs. 0%, P = 0.01). The rate of pneumonia in the target lobe in the EBV group was 4.2% at 12 months. Greater radiographic evidence of emphysema heterogeneity and fissure completeness was associated with an enhanced response to treatment.

CONCLUSIONS

Endobronchial-valve treatment for advanced heterogeneous emphysema induced modest improvements in lung function, exercise tolerance, and symptoms at the cost of more frequent exacerbations of COPD, pneumonia, and hemoptysis after implantation.”
“In

this study we present a competition model between a non-chelator (e.g. pathogen) microorganism and an iron chelator microorganism (e.g. Pseudomonas fluorescens). This latter is a beneficial bacteria that can inhibit the growth of the non-chelator through its iron chelating capability. This phenomena of iron chelation is shown to prevent the pathogen from proliferating to numbers capable of causing disease. A mathematical model is formulated and used to study this competition.

The model proposes a new and simple conceptual explanation of interactions. It is a nonlinear system of ordinary differential equations. A qualitative analysis of the model for the batch case (no inflow or outflow from the system) is carried out and the global Epothilone B (EPO906, Patupilone) behavior of the model variables is studied. For the chemostat case, the equilibrium points were derived and their stability was performed through extensive numerical simulations. It is found that iron chelation is able to control the non-chelator microorganism growth under a wide range of conditions. (C) 2009 Elsevier Ltd. All rights reserved.”
“BACKGROUND

Studies have shown that telephone interventions designed to promote patients’ self-management skills and improve patient-physician communication can increase patients’ satisfaction and their use of preventive services. The effect of such a strategy on health care costs remains controversial.